Trial Profile
A Randomized, Double-blind, Placebo-controlled Parallel Group, Multicenter Trial to Evaluate the Efficacy and Safety of Multiple Dose Administration of an Intravenous Formulation of Tapentadol in the Treatment of Acute Pain Following Bunionectomy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 15 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 31 Oct 2011 Actual initiation date (Sep 2011) added as reported by ClinicalTrials.gov.